Log Type Authored on Log Message Log Node Authored by
Newsletter opened Opened Анонимен
Newsletter opened Opened Анонимен
Newsletter opened Opened Анонимен
Newsletter opened Opened Анонимен
Newsletter opened Opened Анонимен
Newsletter subscribed Newsletter subscribed - Progress in Mind SEA Анонимен
User created User created Анонимен
Newsletter opened Opened Анонимен
OWA Status israel@progress.im manually updating trust level from 1 to 5 Анонимен
User created User created Анонимен
Newsletter opened Opened Анонимен
Newsletter opened Opened Convite Lundbeck Webinar Internacional Анонимен
Newsletter opened Opened Sua atualização semanal em 5 minutos sobre Psiquiatria e Neurologia Анонимен
Newsletter opened Opened Анонимен
Newsletter clicked Clicked https://brazil.progress.im/pt-br/content/apoio-pr%C3%A1tico-%C3%A0-sa%C3%BAde-mental-em-tempos-de-crise Mantenha-se atualizado em apenas 5 minutos sobre Psiquiatria e Neurologia Анонимен
OWA Status Updating trust level from 1 to 2 Анонимен
Newsletter subscribed Newsletter subscribed - Progress in Mind Brazil newsletter Анонимен
User created User created Анонимен
Newsletter opened Opened Mantenha-se atualizado em apenas 5 minutos sobre Psiquiatria e Neurologia Анонимен
Newsletter clicked Clicked https://brazil.progress.im/pt-br/content/apoio-pr%C3%A1tico-%C3%A0-sa%C3%BAde-mental-em-tempos-de-crise Mantenha-se atualizado em apenas 5 minutos sobre Psiquiatria e Neurologia Анонимен
Newsletter opened Opened Mantenha-se atualizado em apenas 5 minutos sobre Psiquiatria e Neurologia Анонимен
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Анонимен
Newsletter clicked Clicked https://japan.progress.im/ja/content/%E5%8F%8C%E6%A5%B5%E6%80%A7%E9%9A%9C%E5%AE%B3%E3%81%AB%E3%81%8A%E3%81%91%E3%82%8B%E8%AA%8D%E7%9F%A5%E6%A9%9F%E8%83%BD%E9%9A%9C%E5%AE%B3%E3%81%AE%E6%A0%B9%E5%BA%95%E3%81%AB%E3%81%82%E3%82%8B%E3%82%82%E3%81%AE%E3%81 Анонимен
Newsletter opened Opened Анонимен
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Анонимен
Log Type Authored on Log Message Log Node Authored by
Newsletter opened Opened Анонимен
Newsletter opened Opened Анонимен
Newsletter opened Opened Анонимен
Newsletter opened Opened Анонимен
Newsletter opened Opened Анонимен
Newsletter subscribed Newsletter subscribed - Progress in Mind SEA Анонимен
User created User created Анонимен
Newsletter opened Opened Анонимен
OWA Status israel@progress.im manually updating trust level from 1 to 5 Анонимен
User created User created Анонимен
Newsletter opened Opened Анонимен
Newsletter opened Opened Convite Lundbeck Webinar Internacional Анонимен
Newsletter opened Opened Sua atualização semanal em 5 minutos sobre Psiquiatria e Neurologia Анонимен
Newsletter opened Opened Анонимен
Newsletter clicked Clicked https://brazil.progress.im/pt-br/content/apoio-pr%C3%A1tico-%C3%A0-sa%C3%BAde-mental-em-tempos-de-crise Mantenha-se atualizado em apenas 5 minutos sobre Psiquiatria e Neurologia Анонимен
OWA Status Updating trust level from 1 to 2 Анонимен
Newsletter subscribed Newsletter subscribed - Progress in Mind Brazil newsletter Анонимен
User created User created Анонимен
Newsletter opened Opened Mantenha-se atualizado em apenas 5 minutos sobre Psiquiatria e Neurologia Анонимен
Newsletter clicked Clicked https://brazil.progress.im/pt-br/content/apoio-pr%C3%A1tico-%C3%A0-sa%C3%BAde-mental-em-tempos-de-crise Mantenha-se atualizado em apenas 5 minutos sobre Psiquiatria e Neurologia Анонимен
Newsletter opened Opened Mantenha-se atualizado em apenas 5 minutos sobre Psiquiatria e Neurologia Анонимен
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Анонимен
Newsletter clicked Clicked https://japan.progress.im/ja/content/%E5%8F%8C%E6%A5%B5%E6%80%A7%E9%9A%9C%E5%AE%B3%E3%81%AB%E3%81%8A%E3%81%91%E3%82%8B%E8%AA%8D%E7%9F%A5%E6%A9%9F%E8%83%BD%E9%9A%9C%E5%AE%B3%E3%81%AE%E6%A0%B9%E5%BA%95%E3%81%AB%E3%81%82%E3%82%8B%E3%82%82%E3%81%AE%E3%81 Анонимен
Newsletter opened Opened Анонимен
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Анонимен